KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference Sep 05, 2024 7:00am EDT
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance Aug 07, 2024 4:05pm EDT
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference Jul 25, 2024 4:05pm EDT
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda Jul 24, 2024 4:05pm EDT
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 Jul 17, 2024 4:05pm EDT
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan Jul 02, 2024 7:00am EDT
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion Jun 05, 2024 9:00am EDT
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic Jun 04, 2024 4:03pm EDT
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic May 14, 2024 4:05pm EDT
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth May 01, 2024 4:05pm EDT
